Viewing StudyNCT00098774



Ignite Creation Date: 2024-05-05 @ 11:38 AM
Last Modification Date: 2024-10-26 @ 9:11 AM
Study NCT ID: NCT00098774
Status: COMPLETED
Last Update Posted: 2016-07-06
First Post: 2004-12-08

Brief Title: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma
Sponsor: Alliance for Clinical Trials in Oncology
Organization: Alliance for Clinical Trials in Oncology

Organization Data

Organization: Alliance for Clinical Trials in Oncology
Class: OTHER
Study ID: CALGB-50202
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Alliance for Clinical Trials in Oncology
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
National Cancer Institute NCI NIH